Home ETF List About

Portfolio Holdings Detail for ISIN IE00BP3QZB59
Stock Name / FundiShares Edge MSCI World Value Factor UCITS ETF
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerIWFV(GBX) LSE
ETF TickerIS3S(EUR) F
ETF TickerIS3S.DE(EUR) CXE
ETF TickerIWFV.LS(GBX) CXE
ETF TickerIWVL.LS(USD) CXE
ETF TickerIWVL.MI(EUR) CXE
ETF TickerIWVLz(USD) CXE
ETF TickerIWVL(EUR) ETF Plus
ETF TickerIWFV.L(GBP) LSE

Holdings detail for TEVA

Stock NameTeva Pharma Industries Ltd ADR
TickerTEVA(USD) NYSE
TYPECommon Stock
CountryUSA
ISINUS8816242098
LEI549300BAFGM4RC74ZJ94

Show aggregate TEVA holdings

News associated with TEVA

Medincell Reports Positive Phase 3 Safety Data For Olanzapine LAI; No PDSS Observed
(RTTNews) - Medincell SA (MEDCL.PA) reported that new long-term safety data from the completed Phase 3 SOLARIS trial support the potential of Olanzapine LAI (TEV-749) as the first long-acting olanzapine treatment option for schizophrenia, with no post-injection delirium/sedation - 2025-09-22 03:59:28
HEFA, EFA, TEVA, MNDY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Currency Hedged MSCI EAFE ETF (Symbol: HEFA) where we have detected an approximate $98.6 million dollar outflow -- that's a 1.5% decrease we - 2025-09-19 11:50:18
Tuesday's ETF with Unusual Volume: EFG
The iShares MSCI EAFE Growth ETF is seeing unusually high volume in afternoon trading Tuesday, with over 10.5 million shares traded versus three month average volume of about 647,000. Shares of EFG were down about 0.5% on the day. Components of that ETF with the highest volume - 2025-09-16 13:25:58
Noteworthy ETF Inflows: IDEV, CYBR, TEVA, CCEP
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI International Developed Markets ETF (Symbol: IDEV) where we have detected an approximate $366.0 million dollar inflow -- that's a 1 - 2025-09-08 12:03:35
Notable ETF Inflow Detected - IXUS, AER, TEVA, FUTU
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $129.6 million dollar inflow -- that's a 0.3% in - 2025-08-25 13:46:54
Billionaire Stanley Druckenmiller Sold All of His Palantir and Has Piled Into This High-Flying Drug Stock for 4 Consecutive Quarters
Key PointsQuarterly-filed Form 13Fs give investors a way to track which stocks Wall Street's best money managers are buying and selling. - 2025-08-20 04:51:00
US Bancorp DE Has $166,000 Stock Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
US Bancorp DE lifted its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 6.5% in the first quarter, HoldingsChannel reports. The firm owned 10,812 shares of the company’s stock after purchasing an additional 656 shares during the period. US Bancorp DE’s holdings in Teva Pharmaceutical Industries were worth $166,000 at the end […] - 2025-08-17 05:46:51
Deutsche Bank AG Increases Stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Deutsche Bank AG grew its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 16.9% in the 1st quarter, HoldingsChannel reports. The firm owned 2,589,607 shares of the company’s stock after buying an additional 375,064 shares during the quarter. Deutsche Bank AG’s holdings in Teva Pharmaceutical Industries were worth $39,802,000 as of its […] - 2025-08-13 05:18:59
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.71 Consensus PT from Analysts
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1-year price […] - 2025-08-04 02:43:01
Wall Street Zen Upgrades Teva Pharmaceutical Industries (NYSE:TEVA) to Buy
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. TEVA has been the subject of a number of other reports. JPMorgan Chase & Co. upgraded Teva Pharmaceutical Industries from a “neutral” rating […] - 2025-07-28 04:02:50
Signaturefd LLC Trims Stock Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Signaturefd LLC decreased its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 28.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,768 shares of the company’s stock after selling 2,739 shares during the period. Signaturefd LLC’s holdings in […] - 2025-07-22 07:20:51
Head to Head Comparison: Teva Pharmaceutical Industries (NYSE:TEVA) vs. Taysha Gene Therapies (NASDAQ:TSHA)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings. Profitability This table compares Taysha Gene […] - 2025-07-22 02:45:38
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters
Key PointsForm 13Fs provide investors with an over-the-shoulder look at which stocks Wall Street's brightest money managers are buying and selling. - 2025-07-18 04:06:00
Bank of New York Mellon Corp Sells 11,648 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Bank of New York Mellon Corp lessened its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 0.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,609,696 shares of the company’s stock after selling 11,648 shares during […] - 2025-07-17 04:32:51
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Sold by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. trimmed its holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 5.7% during the first quarter, HoldingsChannel reports. The firm owned 1,921,762 shares of the company’s stock after selling 116,779 shares during the period. Envestnet Asset Management Inc.’s holdings in Teva Pharmaceutical Industries were worth $29,537,000 at the end […] - 2025-07-15 05:14:50
DekaBank Deutsche Girozentrale Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
DekaBank Deutsche Girozentrale decreased its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,127 shares of the company’s stock after selling 1,453 shares during the period. DekaBank Deutsche Girozentrale’s […] - 2025-07-14 05:34:47
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Receives $24.13 Consensus Price Target from Analysts
Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) have earned a consensus rating of “Buy” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average […] - 2025-07-10 02:50:52
GAMMA Investing LLC Sells 3,068 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
GAMMA Investing LLC trimmed its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 41.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,390 shares of the company’s stock after selling 3,068 shares during the […] - 2025-07-09 04:24:51
Teva Pharmaceutical Industries Sees Unusually Large Options Volume (NYSE:TEVA)
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Get Free Report) saw some unusual options trading activity on Monday. Stock investors purchased 59,369 put options on the stock. This is an increase of approximately 93% compared to the typical volume of 30,826 put options. Teva Pharmaceutical Industries Stock Down 1.0% TEVA stock opened at $16.84 on Tuesday. […] - 2025-07-08 02:20:24
Retirement Systems of Alabama Makes New Investment in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
Retirement Systems of Alabama acquired a new position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 401,249 shares of the company’s stock, valued at approximately $6,167,000. Other large investors […] - 2025-06-25 05:08:59
IXUS, TEVA, TME, MNDY: ETF Inflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core MSCI Total International Stock ETF (Symbol: IXUS) where we have detected an approximate $593.1 million dollar inflow -- that's a 1.3% in - 2025-06-20 12:07:30
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Holdings Reduced by QRG Capital Management Inc.
QRG Capital Management Inc. lessened its holdings in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA – Free Report) by 12.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 129,430 shares of the company’s stock after selling 18,708 shares during […] - 2025-06-20 05:38:53
Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
There's nothing more valuable on Wall Street than data, and investors rarely have to dig to find something that's pertinent to the U.S. economy, the stock market, or their specific portfolio holdings. - 2025-06-16 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Given Consensus Recommendation of “Buy” by Brokerages
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has been given a consensus rating of “Buy” by the ten brokerages that are presently covering the company, Marketbeat Ratings reports. Eight equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average […] - 2025-06-12 05:30:57
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Sees Large Increase in Short Interest
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 38,700,000 shares, an increase of 36.1% from the April 30th total of 28,430,000 shares. Based on an average trading volume of 12,300,000 […] - 2025-06-04 05:04:50
Monday's ETF with Unusual Volume: EFAA
The Invesco MSCI EAFE Income Advantage ETF is seeing unusually high volume in afternoon trading Monday, with over 217,000 shares traded versus three month average volume of about 30,000. Shares of EFAA were down about 0.1% on the day. Components of that ETF with the highest vo - 2025-06-02 14:56:10
B. Riley Wealth Advisors Inc. Buys New Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)
B. Riley Wealth Advisors Inc. bought a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,689 shares of the company’s stock, valued at approximately $214,000. Other hedge funds and other institutional […] - 2025-06-02 05:40:56
Teva Pharmaceutical Industries (NYSE:TEVA) Now Covered by Truist Financial
Truist Financial assumed coverage on shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) in a report issued on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $25.00 price target on the stock. TEVA has been the topic of several other reports. Barclays reduced their price target on Teva Pharmaceutical Industries from […] - 2025-05-29 03:14:53
Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
The amount of data investors digest daily on Wall Street can sometimes feel overwhelming. Over the last six weeks, investors have navigated their way through earnings season, a Federal Reserve Open Market Committee meeting, and President Donald Trump's regularly changing tariff a - 2025-05-28 04:06:00
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Receives Consensus Recommendation of “Buy” from Analysts
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Buy” from the eight analysts that are presently covering the stock, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price […] - 2025-05-23 06:58:47

iShares Edge MSCI World Value Factor UCITS ETF TEVA holdings

DateNumber of TEVA Shares HeldBase Market Value of TEVA SharesLocal Market Value of TEVA SharesChange in TEVA Shares HeldChange in TEVA Base ValueCurrent Price per TEVA Share HeldPrevious Price per TEVA Share Held
2025-11-11 (Tuesday)466,588TEVA holding decreased by -4917USD 11,725,356TEVA holding increased by 286645USD 11,725,356-4,917USD 286,645 USD 25.13 USD 24.26
2025-11-10 (Monday)471,505TEVA holding increased by 7884USD 11,438,711TEVA holding increased by 325716USD 11,438,7117,884USD 325,716 USD 24.26 USD 23.97
2025-11-07 (Friday)463,621USD 11,112,995TEVA holding decreased by -227175USD 11,112,9950USD -227,175 USD 23.97 USD 24.46
2025-11-06 (Thursday)463,621USD 11,340,170TEVA holding decreased by -64907USD 11,340,1700USD -64,907 USD 24.46 USD 24.6
2025-11-05 (Wednesday)463,621USD 11,405,077TEVA holding increased by 1919391USD 11,405,0770USD 1,919,391 USD 24.6 USD 20.46
2025-11-04 (Tuesday)463,621USD 9,485,686TEVA holding decreased by -27817USD 9,485,6860USD -27,817 USD 20.46 USD 20.52
2025-11-03 (Monday)463,621USD 9,513,503TEVA holding increased by 18545USD 9,513,5030USD 18,545 USD 20.52 USD 20.48
2025-10-31 (Friday)463,621USD 9,494,958TEVA holding increased by 208629USD 9,494,9580USD 208,629 USD 20.48 USD 20.03
2025-10-30 (Thursday)463,621USD 9,286,329TEVA holding decreased by -92724USD 9,286,3290USD -92,724 USD 20.03 USD 20.23
2025-10-29 (Wednesday)463,621USD 9,379,053TEVA holding increased by 208630USD 9,379,0530USD 208,630 USD 20.23 USD 19.78
2025-10-28 (Tuesday)463,621TEVA holding increased by 18208USD 9,170,423TEVA holding increased by 435874USD 9,170,42318,208USD 435,874 USD 19.78 USD 19.61
2025-10-27 (Monday)445,413USD 8,734,549TEVA holding increased by 293973USD 8,734,5490USD 293,973 USD 19.61 USD 18.95
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TEVA by Blackrock for IE00BP3QZB59

Show aggregate share trades of TEVA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-11SELL-4,917 25.130* 17.28 Profit of 84,956 on sale
2025-11-10BUY7,884 24.260* 17.24
2025-10-28BUY18,20819.78019.980 19.960USD 363,432 17.04
2025-10-22BUY1,37718.97019.190 19.168USD 26,394 16.99
2025-10-15BUY1,37719.78020.020 19.996USD 27,534 16.93
2025-09-24BUY1,75419.27019.450 19.432USD 34,084 16.76
2025-09-16BUY87018.68018.930 18.905USD 16,447 16.73
2025-08-15BUY4,34017.86017.900 17.896USD 77,669 16.71
2025-08-05SELL-1,29015.71015.920 15.899USD -20,510 16.72 Profit of 1,054 on sale
2025-07-14SELL-1,34716.42016.740 16.708USD -22,506 16.75 Profit of 57 on sale
2025-06-27BUY8,43616.76016.910 16.895USD 142,526 16.75
2025-06-25SELL-2,69417.00017.180 17.162USD -46,234 16.75 Loss of -1,115 on sale
2025-06-02SELL-5,16017.26017.280 17.278USD -89,154 16.68 Loss of -3,110 on sale
2025-05-30SELL-39,54316.78017.470 17.401USD -688,088 16.67 Loss of -28,729 on sale
2025-05-27SELL-5,19217.71018.010 17.980USD -93,352 16.65 Loss of -6,924 on sale
2025-05-19SELL-3,65617.02017.060 17.056USD -62,357 16.64 Loss of -1,530 on sale
2025-05-15SELL-3,63216.87017.100 17.077USD -62,024 16.63 Loss of -1,613 on sale
2025-05-14SELL-1,80416.89017.500 17.439USD -31,460 16.63 Loss of -1,458 on sale
2025-04-24SELL-91814.72014.770 14.765USD -13,554 16.68 Profit of 1,757 on sale
2025-04-22SELL-1,38014.00014.070 14.063USD -19,407 16.73 Profit of 3,683 on sale
2025-04-10BUY1,82512.82013.950 13.837USD 25,253 17.03
2025-04-09BUY1,57214.16014.330 14.313USD 22,500 17.06
2025-04-07SELL-7,31613.94014.550 14.489USD -106,002 17.14 Profit of 19,408 on sale
2025-04-01SELL-3,66815.29015.470 15.452USD -56,678 17.23 Profit of 6,514 on sale
2025-03-28BUY1,83015.08015.500 15.458USD 28,288 17.28
2025-03-21BUY1,81816.10016.200 16.190USD 29,433 17.37
2025-03-19BUY1,82516.29016.570 16.542USD 30,189 17.40
2025-03-11BUY3,65016.10016.220 16.208USD 59,159 17.49
2025-03-07BUY3,63015.36015.460 15.450USD 56,084 17.57
2025-02-28BUY1,81316.46016.460 16.460USD 29,842 17.67
2025-02-20BUY1,81717.00017.630 17.567USD 31,919 17.78
2025-02-03SELL-9,04517.35017.750 17.710USD -160,187 18.08 Profit of 3,340 on sale
2025-01-31SELL-1,80917.73018.320 18.261USD -33,034 18.09 Loss of -313 on sale
2025-01-23SELL-1,80921.79022.110 22.078USD -39,939 17.67 Loss of -7,975 on sale
2025-01-02SELL-54,67421.30022.300 22.200USD -1,213,763 17.56 Loss of -253,527 on sale
2024-12-09SELL-1,82217.60017.760 17.744USD -32,330 17.57 Loss of -320 on sale
2024-12-04SELL-1,82217.80018.250 18.205USD -33,170 17.56 Loss of -1,175 on sale
2024-11-29SELL-3,63616.78016.960 16.942USD -61,601 17.63 Profit of 2,488 on sale
2024-11-25SELL-250,58716.69017.060 17.023USD -4,265,742 17.81 Profit of 197,668 on sale
2024-11-22SELL-2,66417.12017.130 17.129USD -45,632 17.84 Profit of 1,907 on sale
2024-11-21SELL-2,66417.08017.170 17.161USD -45,717 17.88 Profit of 1,923 on sale
2024-11-05SELL-2,65818.77018.790 18.788USD -49,939 18.37 Loss of -1,118 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TEVA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-191,326,5673,9412,847,92146.6%
2025-09-181,947,0074,4264,674,64341.7%
2025-09-171,292,03911,6644,003,06232.3%
2025-09-162,251,05334,1784,868,20946.2%
2025-09-152,578,4201,1006,567,43639.3%
2025-09-122,617,2923,8615,387,05448.6%
2025-09-111,863,29620,5674,067,64945.8%
2025-09-102,057,02820,4195,058,82940.7%
2025-09-092,177,3481,4526,082,56535.8%
2025-09-082,198,38610,5265,200,40442.3%
2025-09-051,747,0799,4934,271,66740.9%
2025-09-042,087,4506,8304,093,85851.0%
2025-09-032,032,2261,6005,035,50140.4%
2025-09-022,391,6341,6546,813,17335.1%
2025-08-291,374,4768,9783,008,16845.7%
2025-08-281,177,4872,9463,118,00237.8%
2025-08-271,884,3936,5553,323,17156.7%
2025-08-261,914,1803,2494,260,23844.9%
2025-08-251,407,4634203,321,52342.4%
2025-08-222,604,23506,684,84039.0%
2025-08-213,825,58611,3899,899,00138.6%
2025-08-201,144,0974,8783,530,09532.4%
2025-08-191,739,2672,5246,118,13828.4%
2025-08-181,882,6078,5925,438,37334.6%
2025-08-152,099,82311,0134,305,31648.8%
2025-08-142,419,7941,7065,478,47244.2%
2025-08-131,584,58814,9394,845,26532.7%
2025-08-121,591,6691,5003,589,46744.3%
2025-08-111,671,9143,2004,204,80939.8%
2025-08-082,394,84705,125,37046.7%
2025-08-072,680,05910,9546,786,02139.5%
2025-08-062,688,426464,2865,933,92345.3%
2025-08-052,444,3624035,927,09541.2%
2025-08-042,580,27015,6067,333,66035.2%
2025-08-012,963,212367,2567,094,54541.8%
2025-07-313,200,20711,2499,684,59433.0%
2025-07-304,694,4888,58111,845,32239.6%
2025-07-292,050,8484,0847,443,23327.6%
2025-07-282,220,328596,554,15633.9%
2025-07-251,667,7231,2824,447,67237.5%
2025-07-241,993,9982,3594,968,34340.1%
2025-07-231,911,52610,6915,766,86233.1%
2025-07-221,643,6011354,872,10033.7%
2025-07-211,325,4748003,789,65035.0%
2025-07-181,955,50155,942,64232.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.